SCHEMBL27028464

SCHEMBL27028464

Cn1ncc2c(Cl)nc(C(=O)Cl)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 3/20 0.43
GAA P10253 1/20 0.39
KMT2A Q03164 5/20 0.37
S1PR2 O95136 5/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 3/20 0.35
ATAD2 Q6PL18 1/20 0.35
NR3C1 P04150 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C19 P33261 2/20 0.34
POLB P06746 1/20 0.34
HSP90AA1 P07900 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29950508 1.00 PDE2A (0.43) PDE2AGAAKMT2AS1PR2KDM4E
SCHEMBL4918794 0.80 ALDH1A1 (0.44) GAAKMT2AKDM4EALDH1A1MAPT
SCHEMBL29950553 0.77 NR3C1 (0.36) PDE2AKMT2AKDM4EALDH1A1MAPT
SCHEMBL17889388 0.76 PDE2A (0.47) PDE2AGAAKMT2AKDM4EALDH1A1
SCHEMBL55774 0.75 PDE2A (0.64) PDE2AGAAKMT2AKDM4EALDH1A1
SCHEMBL18343699 0.74 PDE2A (0.49) PDE2AGAAKMT2AKDM4EALDH1A1
SCHEMBL21114478 0.74 PDE2A (0.43) PDE2AGAAKMT2AS1PR2KDM4E
SCHEMBL24954062 0.73 PDE2A (0.47) PDE2AGAAKMT2AKDM4EALDH1A1
SCHEMBL31106964 0.73 PDE2A (0.47) PDE2AGAAKMT2AKDM4EALDH1A1
SCHEMBL21282811 0.70 PDE2A (0.45) PDE2AGAAKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383903-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2024-11-21 US disclosed
US-11964978-B2 Modulators of STING (stimulator of interferon genes) PFIZER INC. (US) 2024-04-23 US disclosed
EP-4308563-A1 MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) Pfizer Inc. (US) 2024-01-24 EP disclosed
US-20220306641-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964978-B2 Modulators of STING (stimulator of interferon genes) STING1, IRF3, CGAS PDE2A 68/4885GAA 372/4885KMT2A 4571/4885
US-20220306641-A1 Modulators of STING (Stimulator of Interferon Genes) STING1, IRF3, CGAS PDE2A 68/4885GAA 372/4885KMT2A 4571/4885
US-20240383903-A1 Modulators of STING (Stimulator of Interferon Genes) STING1, IRF3, CGAS PDE2A 68/4885GAA 372/4885KMT2A 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.